Insider Trading History of Gurney Austin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Gurney Austin since 2014. The trader's CIK number is 1553353. At the time of the last reporting, Gurney Austin was the See Remarks of Oncomed Pharmaceuticals Inc. (stock ticker symbol OMED). Also see all insider trading activities at Oncomed Pharmaceuticals Inc.


Yearly summary of insider trading at Oncomed Pharmaceuticals Inc (OMED) by Gurney Austin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 OMED 0 $0 18,010 $23,430 0 $0
2017 OMED 0 $0 7,002 $56,884 0 $0
2016 OMED 0 $0 2,162 $47,390 0 $0
2015 OMED 0 $0 48,000 $1,076,503 0 $0
2014 OMED 0 $0 28,000 $582,756 0 $0


Insider trading of Oncomed Pharmaceuticals Inc (OMED) by Gurney Austin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-24 OMED Sale 11,117 .60 6,670
2018-10-10 OMED Sale 1,156 2.01 2,323
2018-10-09 OMED Sale 1,686 2.13 3,589
2018-04-24 OMED Sale 4,051 2.68 10,848
2017-10-10 OMED Sale 1,248 4.26 5,311
2017-04-04 OMED Sale 5,754 8.96 51,573
2016-01-06 OMED Sale 2,161 21.92 47,369
2016-01-07 OMED Sale 1 21.33 21
2015-10-26 OMED Sale 14,000 20.00 280,000
2015-07-29 OMED Sale 7,000 20.68 144,760
2015-07-30 OMED Sale 7,000 21.24 148,687
2015-05-18 OMED Sale 4,000 22.76 91,040
2015-04-17 OMED Sale 4,000 26.00 103,980
2015-03-17 OMED Sale 4,000 27.37 109,468
2015-02-17 OMED Sale 4,000 26.37 105,492
2015-01-20 OMED Sale 4,000 23.27 93,076
2014-12-17 OMED Sale 4,000 20.00 80,000
2014-11-17 OMED Sale 4,000 20.16 80,660
2014-10-17 OMED Sale 4,000 20.07 80,280
2014-10-02 OMED Sale 4,000 20.00 80,000
2014-08-22 OMED Sale 4,000 20.00 80,000
2014-07-17 OMED Sale 4,000 20.46 81,852
2014-06-17 OMED Sale 4,000 24.99 99,964

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gurney Austin (See Remarks of Oncomed Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.